Hepatoblastoma Clinical Trials

44 clinical trials for Hepatoblastoma across international registries, including 12 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Molecular Basis of Pediatric Liver Cancer — RECRUITING
• ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma — RECRUITING · PHASE1
• B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) — RECRUITING · PHASE1
• A Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy — RECRUITING · PHASE3
• Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies — RECRUITING · PHASE1
• Agnostic Therapy in Rare Solid Tumors — RECRUITING · PHASE2
• Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells — RECRUITING · PHASE1
• A Prospective Multicenter Clinical Study of SCCG Protocol and ctDNA 5hmc in Predicting the Chemotherapy Sensitivity and Monitoring the Recurrence and Metastasis of Hepatoblastoma in Children and Adolescents — RECRUITING · PHASE2
• Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells — RECRUITING · PHASE1
• Pucotenlimab Combined With Lenvatinib and Chemotherapy in the Treatment of Advanced, Relapsed/Refractory Hepatoblastoma in Children — RECRUITING · NA
• A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers — RECRUITING
• Randomized controlled trial on Pringle Maneuver to reduce blood loss during Stapler Hepatectomy - PriMal StHep — RECRUITING
• Accurate Diagnosis and Grading of Pediatric Solid Tumors Based on Pathological Large Models — COMPLETED
• Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors — ACTIVE_NOT_RECRUITING · PHASE2
• Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery — ACTIVE_NOT_RECRUITING · PHASE3
• Paediatric Hepatic International Tumour Trial — ACTIVE_NOT_RECRUITING · PHASE3
• B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults — ACTIVE_NOT_RECRUITING · PHASE1
• EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults — ACTIVE_NOT_RECRUITING · PHASE1
• A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial) — COMPLETED · PHASE2
• Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors — COMPLETED · PHASE2
• Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults With Liver Tumors — TERMINATED
• Psychosocial Situation of Children With Rare Solid Abdominal Tumors and Their Families — COMPLETED
• Evaluation of Lung Metastases Based on Ultrashort Echo Time MRI — COMPLETED
• Diagnostic Efficacy and Prognostic Value of 18F-FDG PET/CT (MR) in Pediatric Solid Blastoma — COMPLETED
• Auto Transplant for High Risk or Relapsed Solid or CNS Tumors — COMPLETED · NA
• Combined Modality Therapy in Hepatoblastoma: South Egypt Cancer Institute Experience — OTHER
• GastroIntestinal Cancer in Children and Adolescents — OTHER
• Evaluation of liver controller models in liver surgery. — OTHER
• Evaluation of the placement of digital image data in liver- and pancreas surgery — NOT_YET_RECRUITING
• Sequential PD-1/PD-L1 Inhibitor and LENvatinib in TLCT and Refractory Hepatoblastoma After Chemotherapy — OTHER · PHASE2
• Deep Learning Magnetic Resonance Imaging Radiomics for Diagnostic Value of Hepatic Tumors in Infants — OTHER
• PIVKA-II Combined With Alpha-Fetoprotein for Diagnostic and Prognostic Value of Hepatic Tumors in Infants — COMPLETED
• Pre- and intraoperative Evaluation of enhanced digital imaging technologies in liver surgery — NOT_YET_RECRUITING
• Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors — COMPLETED · PHASE1
• T Cells co- Expressing a Second Generation Glypican 3-specific Chimeric Antigen Receptor With Cytokines Interleukin-21 and 15 as Immunotherapy for Patients With Liver Cancer (TEGAR) — WITHDRAWN · PHASE1
• Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia — COMPLETED · PHASE2
• Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors — COMPLETED · PHASE1
• G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor — OTHER · PHASE4
• Imetelstat Sodium in Treating Younger Patients With Relapsed or Refractory Solid Tumors — WITHDRAWN · PHASE2
• A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB — COMPLETED · PHASE1
• Hepatoblastoma Biology Study and Tissue Bank — WITHDRAWN · NA
• Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors — OTHER · PHASE1

Refine this search